Carly Newton: Understanding Access to Red Blood Cell Exchange for People Living With SCD
Carly Newton, Sr Manager of Apheresis Clinical Marketing at Terumo Blood and Cell Technologies, shared a post on LinkedIn:
“Proud to see research from Terumo Blood and Cell Technologies highlighted in The Guardian. We surveyed U.S. healthcare providers to better understand access to red blood cell exchange (RBCX) for people living with sickle cell disease.
One finding stands out: 91% of providers surveyed report having access to RBCX, yet fewer than 3% of U.S. patients receive it in a given year.
Access on paper isn’t the same as patients getting care. Closing that gap means connecting people with specialized care teams and the resources they need to manage this disease long term.
We’re committed to research that goes beyond our devices to understand the real barriers patients face. More to come, and looking forward to continuing the conversation at AABB 2026 this week and ASH 2026 in December.”
Stay updated with Hemostasis Today.
-
Oct 17, 2026, 02:34Raising Awareness of Blood Clots During and After Pregnancy – Thrombosis UK
-
Oct 17, 2026, 02:33Alaa Salamat: Our Research Accepted for Publication at ASH 2026
-
Oct 17, 2026, 02:32Mohammed Al Sharif: Discussing Factor XIII Testing and Its Clinical Significance
-
Oct 17, 2026, 02:31Joanna Popiolek-Kalisz: Talking about Novel Pharmacotherapy for Hypertension at CV Prevention and Intervention
-
Oct 17, 2026, 02:00How Antiphospholipid Syndrome Can Affect the Adrenal Glands – APS Foundation of America
-
Oct 17, 2026, 01:59Liza-Marie Johnson: How Far Should Clinicians Go to Influence Parents’ Decisions?
-
Oct 17, 2026, 01:54Jim Hoffman: The Importance of Self-Advocacy and Understanding Autoimmune Mechanisms
-
Oct 17, 2026, 01:53Kristopher Jonas: Listening to Patients and Recognizing the Donors Who Make Treatment Possible
-
Oct 16, 2026, 18:12Adil Nawaz: Extended Dual Antiplatelet Therapy After Coronary Stenting